A6950
Acetyl-Lys-D-Ala-D-Ala
≥95% (HPLC), powder
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Produtos recomendados
Nome do produto
Acetyl-Lys-D-Ala-D-Ala, ≥95% (HPLC)
Nível de qualidade
Ensaio
≥95% (HPLC)
Formulário
powder
solubilidade
water: 10 mg/mL, clear, colorless
temperatura de armazenamento
−20°C
cadeia de caracteres SMILES
CC(NC(=O)C(C)NC(=O)C(CCCCN)NC(C)=O)C(O)=O
InChI
1S/C14H26N4O5/c1-8(12(20)17-9(2)14(22)23)16-13(21)11(18-10(3)19)6-4-5-7-15/h8-9,11H,4-7,15H2,1-3H3,(H,16,21)(H,17,20)(H,18,19)(H,22,23)
chave InChI
GMSXMADYKTYBCP-UHFFFAOYSA-N
Substratos
Substrate for carboxypeptidase G and DD from Streptomyces albus.
Código de classe de armazenamento
11 - Combustible Solids
Classe de risco de água (WGK)
WGK 3
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Escolha uma das versões mais recentes:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Science (New York, N.Y.), 280(5364), 711-714 (1998-05-23)
The cooperativity between binding of cell wall precursor analogs (ligands) to and antibiotic dimerization of the clinically important vancomycin group antibiotics was investigated by nuclear magnetic resonance. When dimerization was weak in the absence of a ligand, the increase in
European journal of biochemistry, 162(3), 525-531 (1987-02-02)
Titration of the active-site serine DD-peptidase of Streptomyces R61 shows that formation of acyl enzyme during hydrolysis of the substrate Ac2-L-Lys-D-Ala-D-Ala and enzyme inactivation by the beta-lactam compounds benzylpenicillin, N-acetylampicillin and ampicillin relies on the acidic form of an enzyme's
The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.
Structure (London, England : 1993), 2(8), 747-754 (1994-08-15)
Glycopeptide antibiotics of the vancomycin group are of crucial clinical importance in the treatment of methicillin resistant Staphylococcus aureus (MRSA)--the often lethal 'super-bug'--characterized by its resistance to a wide range of antibiotics in common use. The antibiotics exert their physiological
Journal of bacteriology, 202(20) (2020-08-12)
Uropathogenic Escherichia coli (UPEC) is the leading cause of human urinary tract infections (UTIs), and many patients experience recurrent infection after successful antibiotic treatment. The source of recurrent infections may be persistent bacterial reservoirs in vivo that are in a
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica